TREATMENT OF GASTRODUODENAL ULCERATIVE DISEASE WITH SODIUM ALKYL SULFATE
- 1 March 1944
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Internal Medicine
- Vol. 73 (3), 212-216
- https://doi.org/10.1001/archinte.1944.00210150015003
Abstract
Our results from the treatment of gastroduodenal ulcerative disease with sodium alkyl sulfate are being reported now because this new therapy has already enabled patients with ulcer to enter the armed forces, and essential war workers previously incapacitated by this disease to return to industry. Palmer1 has shown that gastroduodenal ulcerative disease is the major cause of medical disability in both the English and the American forces. Since it is usually present in male adults during the years of their greatest productivity, the impairment of war effort by this prevalent disease is of serious significance. Most patients with ulcer are now being treated by a routine which has for its goal reduction of intragastric acidity. This type of medication has not been completely satisfactory because a large number of patients with gastroduodenal ulcerative disease respond inadequately to this orthodox management. To date the emphasis has been placed on theThis publication has 1 reference indexed in Scilit:
- THE ESTIMATION OF PEPSIN, TRYPSIN, PAPAIN, AND CATHEPSIN WITH HEMOGLOBINThe Journal of general physiology, 1938